Recruiting NCT07058935
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Valve Disease, Heart. Basic parameters: from 21 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Australia, Hong Kong, India, New Zealand, Singapore +1
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.
Primary outcome measures
- All-cause mortality [Time frame: From date of procedure to 10 years]
Eligibility criteria
Inclusion criteria
- Age ≥ 21
- Had at least one documented Mitral valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Mitral valve-in-valve/valve-in-ring procedure. (Prospective) OR Had at least one documented Tricuspid valve-in-valve/valve-in-ring procedure done during the period of 1 Jan 2023 to current date. (Retrospective) OR Planned to undergo a Tricuspid valve-in-valve/valve-in-ring procedure. (Prospective)
Exclusion criteria
- Active endocarditis
- Any other conditions which investigator deems unsuitable for participation.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
Hong Kong · 2 centers
- Prince of Wales Hospital — Hong Kong
- Queen Elizabeth Hospital — Hong Kong
India · 2 centers
- MGM Healthcare Pvt Ltd — Chennai
- The Madras Medical Mission — Chennai
Australia · 1 center
- John Hunter Hospital — New Lambton Heights
New Zealand · 1 center
- Waikato Hospital — Hamilton
Singapore · 1 center
- National Heart Centre Singapore — Singapore
Thailand · 1 center
- Ramathibodi Hospital — Bangkok
Identifiers
NCT: NCT07058935 · 2024-4264